U Graefe

712 total citations
21 papers, 480 citations indexed

About

U Graefe is a scholar working on Surgery, Nephrology and Clinical Biochemistry. According to data from OpenAlex, U Graefe has authored 21 papers receiving a total of 480 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 3 papers in Nephrology and 3 papers in Clinical Biochemistry. Recurrent topics in U Graefe's work include Metabolism and Genetic Disorders (3 papers), Dialysis and Renal Disease Management (3 papers) and Neurological and metabolic disorders (3 papers). U Graefe is often cited by papers focused on Metabolism and Genetic Disorders (3 papers), Dialysis and Renal Disease Management (3 papers) and Neurological and metabolic disorders (3 papers). U Graefe collaborates with scholars based in Germany and United States. U Graefe's co-authors include Martin Tepel, Walter Zidek, Reiner Riezler, J. Bachmann, Hugo Van Aken, Matthias L. Riess, Hans-Georg Bone, Christiane Goeters, Bernhard F. Henning and Klaus Langer and has published in prestigious journals such as Annals of Internal Medicine, Journal of the American Society of Nephrology and Critical Care Medicine.

In The Last Decade

U Graefe

18 papers receiving 453 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
U Graefe Germany 8 206 166 147 75 70 21 480
Piotr Okoński Poland 10 46 0.2× 20 0.1× 67 0.5× 213 2.8× 352 5.0× 28 659
Duncan R. Walker United Kingdom 17 68 0.3× 9 0.1× 260 1.8× 42 0.6× 76 1.1× 43 725
R. K. Krothapalli United States 7 88 0.4× 20 0.1× 238 1.6× 25 0.3× 44 0.6× 8 658
Yoshihiko Ohnishi Japan 18 43 0.2× 18 0.1× 468 3.2× 54 0.7× 140 2.0× 86 910
Joel Symons Australia 8 16 0.1× 15 0.1× 336 2.3× 149 2.0× 52 0.7× 12 551
Jai‐Hyun Hwang South Korea 18 42 0.2× 18 0.1× 463 3.1× 155 2.1× 46 0.7× 56 775
Nobuyuki Kawazoe Japan 12 316 1.5× 14 0.1× 172 1.2× 5 0.1× 3 0.0× 30 655
M. R. SALEM United States 15 25 0.1× 4 0.0× 241 1.6× 172 2.3× 71 1.0× 57 609
Siniša Dimković Serbia 13 134 0.7× 17 0.1× 82 0.6× 5 0.1× 8 0.1× 27 470
Juha Nissinen Finland 14 26 0.1× 17 0.1× 317 2.2× 37 0.5× 74 1.1× 30 663

Countries citing papers authored by U Graefe

Since Specialization
Citations

This map shows the geographic impact of U Graefe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U Graefe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U Graefe more than expected).

Fields of papers citing papers by U Graefe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by U Graefe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U Graefe. The network helps show where U Graefe may publish in the future.

Co-authorship network of co-authors of U Graefe

This figure shows the co-authorship network connecting the top 25 collaborators of U Graefe. A scholar is included among the top collaborators of U Graefe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with U Graefe. U Graefe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bokemeyer, Bernd, Sandra Plachta‐Danielzik, Wolfgang Mohl, et al.. (2020). P726 Effectiveness of vedolizumab therapy in a real-world setting in Germany: First results of the VEDOibd study comparing vedolizumab to the use of other biologics. Journal of Crohn s and Colitis. 14(Supplement_1). S584–S584. 1 indexed citations
2.
Graefe, U & Martin Keuchel. (2019). Unusual “Worms” in the Small Intestine. Deutsches Ärzteblatt international. 116(10). 176–176.
3.
Riess, Matthias L., U Graefe, Christiane Goeters, Hugo Van Aken, & Hans-Georg Bone. (2002). Sedation assessment in critically ill patients with bispectral index. European Journal of Anaesthesiology. 19(1). 18–18. 58 indexed citations
4.
Riess, Matthias L., U Graefe, Christiane Goeters, Hugo Van Aken, & Hans-Georg Bone. (2002). Sedation assessment in critically ill patients with bispectral index. European Journal of Anaesthesiology. 19(1). 18–22. 16 indexed citations
5.
Henning, Bernhard F., Walter Zidek, Reiner Riezler, U Graefe, & Martin Tepel. (2001). Homocyst(e)ine metabolism in hemodialysis patients treated with vitamins B6, B12 and folate.. PubMed. 200(3). 155–68. 16 indexed citations
6.
Henning, Bernhard F., Reiner Riezler, Martin Tepel, et al.. (1999). Evidence of Altered Homocysteine Metabolism in Chronic Renal Failure. ˜The œNephron journals/Nephron journals. 83(4). 314–322. 37 indexed citations
7.
Riess, Matthias L., U Graefe, Hugo Van Aken, & Hans G. Bone. (1999). USEFULNESS OF BISPECTRAL INDEX™ TO ASSESS THE LEVEL OF SEDATION IN CRITICALLY ILL PATIENTS. Critical Care Medicine. 27(Supplement). A132–A132. 4 indexed citations
8.
Bachmann, J., et al.. (1995). Hyperhomocysteinemia and the risk for vascular disease in hemodialysis patients.. Journal of the American Society of Nephrology. 6(1). 121–125. 150 indexed citations
9.
Langer, Klaus, et al.. (1990). [Long-term results following kidney transplantation. An empirical analysis of 467 allogeneic kidney transplants concerning the effect of clinical and immunological variables on graft function].. PubMed. 85(11). 637–42. 1 indexed citations
10.
Vischer, Peter, et al.. (1989). Chronic renal failure and atherogenesis. Influence of serum factors on prostaglandin synthesis in endothelial cells.. PubMed. 301. 383–8. 1 indexed citations
11.
Graefe, U, et al.. (1986). Zur Häufigkeit von Bindehaut- und Hornhautveränderungen bei Dialysepatienten. Klinische Monatsblätter für Augenheilkunde. 189(11). 419–420. 2 indexed citations
12.
Graefe, U. (1983). [Hemodynamic and metabolic aspects of bicarbonate dialysis].. PubMed. 4(4-5). 225–7. 1 indexed citations
13.
Graefe, U. (1982). [Dialysis treatment in chronic, terminal kidney diseases].. PubMed. 91(9). 42–3. 2 indexed citations
14.
Graefe, U, et al.. (1979). Death Caused by Brain Herniation During Hemodialysis. Southern Medical Journal. 72(4). 418–419. 4 indexed citations
15.
Milutinovic, Jovan, et al.. (1978). Mathematical formulation of the dialysis index for middle molecules, D1(MM).. PubMed. 2(1). 51–4. 2 indexed citations
16.
Graefe, U, et al.. (1978). Less Dialysis-Induced Morbidity and Vascular Instability with Bicarbonate in Dialysate. Annals of Internal Medicine. 88(3). 332–336. 144 indexed citations
17.
Milutinovic, Jovan, A. L. Babb, Joseph W. Eschbach, et al.. (1978). Uremic Neuropathy: Evidence of Middle Molecule Toxicity. Artificial Organs. 2(1). 45–51. 7 indexed citations
18.
Graefe, U, et al.. (1977). Improved tolerance to rapid ultrafiltration with the use of bicarbonate in dialysate.. PubMed. 14. 153–9. 6 indexed citations
19.
Schmer, Gottfried, et al.. (1977). CLINICAL USE OF A TOTALLY HEPARIN GRAFTED HEMODIALYSIS SYSTEM IN UREMIC PATIENTS. ASAIO Journal. 23(1). 177–183. 8 indexed citations
20.
Graefe, U, et al.. (1976). Reduction in dialysis-induced morbidity and vascular instability with the use of bicarbonate in dialysate.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 6. 203–9. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Piotr Okoński Breakdown of academic impact, for papers by Duncan R. Walker Breakdown of academic impact, for papers by R. K. Krothapalli Breakdown of academic impact, for papers by Yoshihiko Ohnishi Breakdown of academic impact, for papers by Joel Symons Breakdown of academic impact, for papers by Jai‐Hyun Hwang Breakdown of academic impact, for papers by Nobuyuki Kawazoe Breakdown of academic impact, for papers by M. R. SALEM Breakdown of academic impact, for papers by Siniša Dimković Breakdown of academic impact, for papers by Juha Nissinen
Rankless by CCL
2026